This page contains brief information about recombinant interferon alfa-2b and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.
FDA label information for this drug is available at DailyMed.
Use in Cancer
Recombinant interferon alfa-2b is approved to treat:
- AIDS-related Kaposi sarcoma. It is used in certain patients who do not have many symptoms of the disease.
- Hairy cell leukemia.
- Melanoma. It is used as adjuvant therapy in patients who have had surgery and have a high risk of recurrent cancer.
- Non-Hodgkin lymphoma (NHL). It is used for aggressive follicular NHL and given with combination chemotherapy.
Recombinant interferon alfa-2b is also being studied in the treatment of other types of cancer and other conditions.
More About Recombinant Interferon Alfa-2b
Definition from the TCH Drug Dictionary – Detailed scientific definition and other names for this drug.
MedlinePlus Information on Recombinant Interferon Alfa-2b – A lay language summary of important information about this drug that may include the following:
- warnings about this drug,
- what this drug is used for and how it is used,
- what you should tell your doctor before using this drug,
- what you should know about this drug before using it,
- other drugs that may interact with this drug, and
- possible side effects.
Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for. This patient information sheet applies only to approved uses of the drug. However, much of the information may also apply to unapproved uses that are being studied.